Elanco Animal Health Inc
Company Stats
- Market Cap
- $11.2B
- as of Sep 30, 2026
- Enterprise Value
- $14.4B
- Shares Outstanding
- 499.6M
- Free Float
- 17.4%
Income Statement
- Revenue
- $4.7B
- Net Income
- -$232.0M
- Non-cash Impairment
- $71.0M
- Revenue Growth, 3Y
- 2.2%
- FCF Margin, 3Y Avg
- 6.0%
- FCF Margin, Worst Year
- 3.0%
Cash Flow
- Free Cash Flow
- $284.0M
- FCF Yield
- 2.5%
- Owner FCF Yield
- 1.9%
Balance Sheet
- Cash & Equivalents
- $545.0M
- Total Debt
- $3.8B
- Net Debt
- $3.2B
Returns & Capital
- SBC, 3Y Avg
- $56.3M
Cash Flow by Year
| Year | Revenue | FCF | Margin |
|---|---|---|---|
| FY2025 | $4.7B | $284.0M | 6.0% |
| FY2024 | $4.4B | $394.0M | 8.9% |
| FY2023 | $4.4B | $131.0M | 3.0% |
| FY2022 | $4.4B | $281.0M | 6.4% |
| FY2021 | $4.8B | $324.0M | 6.8% |
Annual filing data through FY ended December 31, 2025; shares and float as of October 13, 2026. Yields and enterprise value use the calculated market cap above, at its as-of date. Ratios are our calculations from reported figures.
Stronger demand supports expansion as pricing diverges
Chemours and Chiron Lead Weekly Insider Buying Clusters
Healthcare Earnings: Demand Surges, Costs Bite Back